“Tumor Dormancy,” with H. Kim Lyerly, MD, FACS

By Melissa Sakow - November 15, 2016

H. Kim Lyerly, M.D., FACS, discusses research in tumor dormancy in breast cancer, including the role of disseminated tumor cells, bone marrow, and the potential for immune responses to control or prevent recurrences. Dr. Lyerly is Director of the Center of Applied Therapeutics at Duke University.


National Helpline:
844-ASK-SHARE